行情

EGRX

EGRX

Eagle制药
NASDAQ

实时行情|Nasdaq Last Sale

48.45
+1.23
+2.60%
盘后: 48.45 0 0.00% 16:00 07/10 EDT
开盘
47.14
昨收
47.22
最高
48.91
最低
46.84
成交量
13.68万
成交额
--
52周最高
64.94
52周最低
33.80
市值
6.63亿
市盈率(TTM)
300.37
分时
5日
1月
3月
1年
5年

分析师评级

4位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测EGRX价格均价为51.67,最高价位59.00,最低价为46.00。

EPS

EGRX 新闻

更多
CMS Establishes Unique J-Code for Eagle Pharmaceuticals’ PEMFEXY™ (Pemetrexed for Injection)
Eagle Pharmaceuticals, Inc. ("Eagle" or the "Company") (NASDAQ: EGRX) today announced that the Centers for Medicare & Medicaid Services (CMS) has established a unique, product-specific billing code for PEMFEXY™ (pemetrexed for injection). This new Healthcare C
Business Wire · 2天前
The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus
Biotech stocks rebounded in the holiday-shortened week ending July 2 as investors reacted to pending clinical trial readouts and the news flow surrounding COVID-19 vaccine and treatment development. 
Benzinga · 5天前
Stocks To Watch: Postmates, Walgreens And Cannabis Plays
Seeking Alpha - Article · 07/04 12:17
Attention Biotech Investors: Mark Your Calendar For These July PDUFA Dates
The busy calendar of June proved positive for drug approvals, with most scheduled events producing positive outcomes. New molecular entity, or NME, approval for the month totaled two, taking the total NME approvals for the year to 24.
Benzinga · 07/01 14:05
Hedge Funds Are Buying Eagle Pharmaceuticals Inc (EGRX)
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain
Insider Monkey · 06/28 01:28
Edited Transcript of EGRX earnings conference call or presentation 11-May-20 12:30pm GMT
Thomson Reuters StreetEvents · 06/10 21:08
States go after generic drugmakers for alleged price fixing
Seeking Alpha - Article · 06/10 15:39
Eagle Pharmaceuticals to Present at June Investor Conferences
Business Wire · 05/26 21:30

所属板块

制药
-0.31%
制药与医学研究
-0.32%

热门股票

代码
价格
涨跌幅

EGRX 简况

Eagle Pharmaceuticals, Inc.是一家专业制药公司。该公司致力于开发和销售重症监护和肿瘤学领域的注射产品。该公司的产品组合包括EP-1101(阿加曲班)、Ryanodex(丹曲林钠)、多西他赛注射剂、非酒精制剂(非酒精多西他赛注射)、双氯芬酸 - 米索前列醇、EP-3101(盐酸苯达莫司汀注射液,即用型稀释液(RTD)浓缩液)和EP-3102(快速输注的苯达莫司汀RTD)(EP-3102 Bendeka)。它在开发的高级阶段的四个候选产品正在由美国食品和药物管理局(FDA)审查进行批准,包括EP-6101康吉奥即用型(RTU)比伐卢定、用于劳力性热射病的EP-4104(丹曲林钠)(EP-4104)和EP-5101(培美曲塞)(EP-5101)。其近期候选产品,Kangio是一种用于经皮腔内血管成形术的比伐卢定液体静脉注射产品。
展开

微牛提供Eagle Pharmaceuticals Inc(NASDAQ-EGRX)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的EGRX股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易EGRX股票基本功能。